Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Navidea Biopharmaceuticals, Inc. (NEOP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Navidea Biopharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 810509.
Total stock buying since 2014: $5,946,238.
Total stock sales since 2014: $282,111.
Total stock option exercises since 2014: $19,500.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 3,260 | $0 | 0 | $0 | 0 | $0 |
| 2021 | 71,500 | $136,585 | 0 | $0 | 0 | $0 |
| 2020 | 2,388,529 | $2,058,249 | 0 | $0 | 0 | $0 |
| 2019 | 4,927,498 | $3,574,381 | 0 | $0 | 0 | $0 |
| 2017 | 52,959 | $25,318 | 0 | $0 | 0 | $0 |
| 2015 | 10,000 | $13,100 | 120,000 | $200,571 | 0 | $0 |
| 2014 | 125,000 | $138,605 | 60,000 | $81,540 | 50,000 | $19,500 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-04 | 3,260 | $0 | 0 | $0 | 0 | $0 |
| 2021-09 | 20,000 | $31,960 | 0 | $0 | 0 | $0 |
| 2021-07 | 15,000 | $25,470 | 0 | $0 | 0 | $0 |
| 2021-03 | 36,500 | $79,155 | 0 | $0 | 0 | $0 |
| 2020-12 | 5,000 | $10,350 | 0 | $0 | 0 | $0 |
| 2020-08 | 5,000 | $25,000 | 0 | $0 | 0 | $0 |
| 2020-02 | 2,378,529 | $2,022,899 | 0 | $0 | 0 | $0 |
| 2019-12 | 555,555 | $499,999 | 0 | $0 | 0 | $0 |
| 2019-06 | 4,001,000 | $3,001,258 | 0 | $0 | 0 | $0 |
| 2019-05 | 13,800 | $23,124 | 0 | $0 | 0 | $0 |
| 2019-03 | 357,143 | $50,000 | 0 | $0 | 0 | $0 |
| 2017-06 | 20,000 | $10,580 | 0 | $0 | 0 | $0 |
| 2017-05 | 32,959 | $14,738 | 0 | $0 | 0 | $0 |
| 2015-12 | 0 | $0 | 12,500 | $18,750 | 0 | $0 |
| 2015-11 | 0 | $0 | 12,500 | $24,750 | 0 | $0 |
| 2015-10 | 0 | $0 | 12,500 | $28,375 | 0 | $0 |
| 2015-09 | 0 | $0 | 12,500 | $23,512 | 0 | $0 |
| 2015-08 | 0 | $0 | 12,500 | $21,325 | 0 | $0 |
| 2015-07 | 0 | $0 | 12,500 | $20,137 | 0 | $0 |
| 2015-06 | 0 | $0 | 12,500 | $15,537 | 0 | $0 |
| 2015-05 | 10,000 | $13,100 | 12,500 | $16,625 | 0 | $0 |
| 2015-04 | 0 | $0 | 20,000 | $31,560 | 0 | $0 |
| 2014-12 | 0 | $0 | 0 | $0 | 50,000 | $19,500 |
| 2014-11 | 110,000 | $118,070 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-10 | Scott John K Jr. (Director) | Buy | 3,260 | .00 | 0 |
| 2021-09-17 | Witter Malcolm G (Director) | Buy | 20,000 | 1.60 | 31,960 |
| 2021-07-26 | Witter Malcolm G (Director) | Buy | 15,000 | 1.70 | 25,470 |
| 2021-03-29 | Witter Malcolm G (Director) | Buy | 21,500 | 2.07 | 44,505 |
| 2021-03-03 | Witter Malcolm G (Director) | Buy | 15,000 | 2.31 | 34,650 |
| 2020-12-28 | Witter Malcolm G (Director) | Buy | 5,000 | 2.07 | 10,350 |
| 2020-08-30 | Scott John K Jr. (10% Owner) | Buy | 5,000 | 5.00 | 25,000 |
| 2020-02-20 | Latkin Jed (CEO, COO & CFO) | Buy | 5,000 | 1.08 | 5,400 |
| 2020-02-13 | Scott John K Jr. (10% Owner) | Buy | 2,373,529 | .85 | 2,017,499 |
| 2019-12-06 | Scott John K Jr. (10% Owner) | Buy | 555,555 | .90 | 499,999 |
| 2019-06-18 | Scott John K Jr. (10% Owner) | Buy | 4,000,000 | .75 | 3,000,000 |
| 2019-06-05 | Latkin Jed (CEO, COO & CFO) | Buy | 1,000 | 1.26 | 1,258 |
| 2019-05-17 | Rouan Sarah Kathryn (Director) | Buy | 3,350 | 1.46 | 4,904 |
| 2019-05-17 | Latkin Jed (CEO, COO & CFO) | Buy | 1,000 | 1.46 | 1,463 |
| 2019-05-16 | Latkin Jed (CEO, COO & CFO) | Buy | 1,500 | 1.45 | 2,181 |
| 2019-05-15 | Latkin Jed (CEO, COO & CFO) | Buy | 1,000 | 1.45 | 1,448 |
| 2019-05-14 | Latkin Jed (CEO, COO & CFO) | Buy | 2,000 | 1.84 | 3,680 |
| 2019-05-13 | Bruck Claudine (Director) | Buy | 2,550 | 1.90 | 4,855 |
| 2019-05-13 | Latkin Jed (CEO, COO & CFO) | Buy | 2,400 | 1.91 | 4,593 |
| 2019-03-22 | Scott John K Jr. (10% Owner) | Buy | 357,143 | .14 | 50,000 |
| 2017-06-29 | Regan William J. (SVP & CCO) | Buy | 20,000 | .53 | 10,580 |
| 2017-05-30 | Latkin Jed (COO and CFO) | Buy | 7,600 | .44 | 3,313 |
| 2017-05-22 | Latkin Jed (COO and CFO) | Buy | 11,200 | .45 | 5,040 |
| 2017-05-19 | Latkin Jed (COO and CFO) | Buy | 14,159 | .45 | 6,385 |
| 2015-12-01 | Larson Brent L (EVP, CFO, Treas & Sec'y) | Sale | 12,500 | 1.50 | 18,750 |
| 2015-11-02 | Larson Brent L (EVP, CFO, Treas & Sec'y) | Sale | 12,500 | 1.98 | 24,750 |
| 2015-10-01 | Larson Brent L (EVP, CFO, Treas & Sec'y) | Sale | 12,500 | 2.27 | 28,375 |
| 2015-09-01 | Larson Brent L (EVP, CFO, Treas and Sec'y) | Sale | 12,500 | 1.88 | 23,512 |
| 2015-08-03 | Larson Brent L (EVP, CFO, Treas and Sec'y) | Sale | 12,500 | 1.71 | 21,325 |
| 2015-07-01 | Larson Brent L (EVP, CFO, Treas and Sec'y) | Sale | 12,500 | 1.61 | 20,137 |
| 2015-06-01 | Larson Brent L (EVP, CFO, Treas and Sec'y) | Sale | 12,500 | 1.24 | 15,537 |
| 2015-05-29 | Troup Gordon A (Director) | Buy | 10,000 | 1.31 | 13,100 |
| 2015-05-01 | Larson Brent L (EVP, CFO, Treas and Sec'y) | Sale | 12,500 | 1.33 | 16,625 |
| 2015-04-01 | Larson Brent L (EVP, CFO, Treas and Sec'y) | Sale | 20,000 | 1.58 | 31,560 |
| 2014-12-10 | Larson Brent L (EVP, CFO, Treas and Secy) | Option Ex | 50,000 | .39 | 19,500 |
| 2014-11-14 | Goldberg Michael M (Director) | Buy | 28,359 | 1.12 | 31,903 |
| 2014-11-13 | Goldberg Michael M (Director) | Buy | 71,641 | 1.06 | 75,867 |
| 2014-11-10 | Ford Brendan A (Director) | Buy | 10,000 | 1.03 | 10,300 |
| 2014-09-02 | Platinum-montaur Life Sciences, Llc | Sale | 60,000 | 1.36 | 81,540 |
| 2014-05-12 | Regan William J. (SVP-Global Reg Affairs&Quality) | Buy | 5,000 | 1.43 | 7,135 |
| 2014-05-09 | Pykett Mark Jerome (CEO) | Buy | 10,000 | 1.34 | 13,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of NEOP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Navidea Biopharmaceuticals, Inc. (symbol NEOP, CIK number 810509) see the Securities and Exchange Commission (SEC) website.